Merck Receives FDA Approval of ZEPATIER™ (elbasvir and …
https://www.merck.com/news/merck-receives-fda-approval-of-zepatier-elbasvir-and-grazoprevir-for-the-treatment-of-chronic-hepatitis-c-virus-genotype-1-or-4-infection-in-adults-following-priority-review/
WEBJan 28, 2016 · Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review. Save. January 28, 2016 6:59 pm ET.
DA: 77 PA: 26 MOZ Rank: 28